Detalhe da pesquisa
1.
Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG.
Int J Mol Sci
; 21(18)2020 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32942636
2.
Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation.
Am J Med Genet A
; 179(1): 113-117, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30569626
3.
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target.
Front Immunol
; 15: 1356321, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38420122
4.
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.
J Med Chem
; 66(8): 5907-5936, 2023 04 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37017629
5.
Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.
Cell Biosci
; 13(1): 207, 2023 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37957701
6.
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle.
Diagnostics (Basel)
; 12(9)2022 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36140466
7.
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
Front Oncol
; 12: 835642, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35574376
8.
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.
Neuro Oncol
; 24(7): 1150-1163, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34964902
9.
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience.
Ther Adv Med Oncol
; 14: 17588359221113693, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36090803
10.
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches.
Cancers (Basel)
; 13(16)2021 Aug 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34439194
11.
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
J Exp Clin Cancer Res
; 40(1): 364, 2021 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34784956
12.
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy.
Cells
; 10(1)2020 12 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33374128
13.
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas.
Front Oncol
; 8: 526, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30488019
14.
Congenital Extra-Ventricular (Ganglio)Neurocytoma of the Brain Stem: A Case Report.
Front Pediatr
; 6: 108, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29868519
15.
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
Clin Cancer Res
; 24(10): 2395-2407, 2018 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29391353
16.
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
J Exp Clin Cancer Res
; 41(1): 40, 2022 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35086550
17.
Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen.
J Med Chem
; 60(1): 180-201, 2017 01 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28004573
18.
Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9.
Medchemcomm
; 7(8): 1580-1586, 2016 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27746890
19.
HSF1 in Translation.
Cancer Cell
; 24(2): 147-9, 2013 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-23948296
20.
Shock about heat shock in cancer.
Oncotarget
; 3(8): 741-3, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22964629